Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer

Small cell lung cancer (SCLC) is a leading cause of cancer death worldwide, with few treatment options. Rovalpituzumab tesirine (Rova‐T) is an antibody‐drug conjugate that targets delta‐like 3 on SCLC cells to deliver a cytotoxic payload directly to tumor cells. In this study, the cardiac safety pro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Transl Sci
Hauptverfasser: Goldman, Jonathan W., Barve, Minal, Patel, Jyoti D., Wozniak, Antoinette, Dowlati, Afshin, Starodub, Alexander, Owonikoko, Taofeek K., Edenfield, William, Laurie, Scott A., Da Costa, Daniel, Lally, Satwant, Koch, Martina, Kosloski, Matthew P., Hoffman, David, Dy, Grace K.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2020
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7993269/
https://ncbi.nlm.nih.gov/pubmed/33340277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12928
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge